Investigación: Sermorelin

FDA-approved GHRH analog for growth hormone deficiency diagnosis

Treatment of growth-hormone deficiency with growth-hormone-releasing hormone

Lancet 1987 5850 Research Article

GHRH(1-29)NH2 increased height velocity in 12 of 18 GH-deficient children, with 8 showing sustained worthwhile response over 6-18 months of twice-daily injections.